5
TGV Sraac
TGVSL NSE
TGV Sraac
ChemicalsNSE: TGVSL BSE: 507753 Commodity Chemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹1,133 Cr
Volatility
Low Risk
P/E Ratio
8.19
EBITDA
₹366 Cr
Return on Equity
10.18%
Debt to Equity
0.28
Book Value
₹121.14
52W High
₹114.24
52W Low
₹102.5
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.87 times its book value
Weaknesses
2- Company has a low return on equity of 7.26% over last 3 years.
- Dividend payout has been low at 12.5% of profits over last 3 years
Growth Rate
Revenue Growth
11.55% higher than
3Y
Net Income Growth
42.97% higher than
3Y
Cash Flow Change
71.49% lower than
3Y
ROE
29.85% higher than
3Y
ROCE
21.13% lower than
3Y
EBITDA Margin (Avg.)
37.32% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 415 | 360 | 402 | 368 | 379 | 428 | 455 | 487 | 491 | 500 | 448 | 511 | 543 |
| Expenses | 368 | 333 | 358 | 354 | 337 | 360 | 399 | 428 | 396 | 407 | 371 | 426 | 443 |
| Operating Profit | 48 | 27 | 44 | 14 | 42 | 68 | 56 | 59 | 95 | 93 | 77 | 85 | 100 |
| OPM % | 11% | 8% | 11% | 3.8% | 11% | 16% | 12% | 12% | 19% | 19% | 17% | 17% | 18% |
| Other Income | 5 | 24 | 4 | 25 | 3 | 2 | 4 | 5 | 5 | 3 | 6 | 2 | 3 |
| Interest | 5 | 5 | 6 | 7 | 6 | 5 | 6 | 9 | 7 | 6 | 4 | 7 | 6 |
| Depreciation | 20 | 21 | 21 | 22 | 21 | 21 | 21 | 25 | 40 | 40 | 42 | 42 | 36 |
| PBT | 27 | 25 | 21 | 10 | 19 | 44 | 32 | 30 | 52 | 50 | 38 | 38 | 62 |
| Tax % | 27% | 27% | 27% | 28% | 26% | 26% | 26% | 28% | 26% | 26% | 26% | 27% | 27% |
| Net Profit | 20 | 19 | 15 | 7 | 14 | 33 | 24 | 22 | 39 | 37 | 28 | 28 | 45 |
| EPS in Rs | 1.84 | 1.74 | 1.42 | 0.67 | 1.28 | 3.07 | 2.22 | 2.03 | 3.62 | 3.46 | 2.62 | 2.61 | 4.24 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 777 | 816 | 908 | 1,046 | 1,205 | 1,040 | 1,009 | 1,525 | 2,326 | 1,546 | 1,749 | 1,950 | 2,002 |
| Expenses | 669 | 710 | 776 | 866 | 974 | 884 | 860 | 1,219 | 1,786 | 1,412 | 1,520 | 1,595 | 1,647 |
| Operating Profit | 108 | 107 | 132 | 180 | 231 | 157 | 149 | 306 | 539 | 134 | 230 | 355 | 355 |
| OPM % | 14% | 13% | 15% | 17% | 19% | 15% | 15% | 20% | 23% | 9% | 13% | 18% | 18% |
| Other Income | 0 | 5 | 9 | 7 | -6 | 8 | 10 | 7 | 6 | 58 | 14 | 16 | 15 |
| Interest | 40 | 44 | 60 | 58 | 71 | 44 | 48 | 35 | 30 | 25 | 30 | 29 | 22 |
| Depreciation | 36 | 35 | 47 | 77 | 58 | 56 | 63 | 69 | 74 | 84 | 88 | 164 | 160 |
| PBT | 32 | 33 | 34 | 53 | 95 | 64 | 48 | 209 | 442 | 83 | 125 | 178 | 188 |
| Tax % | 30% | 26% | 52% | 44% | 28% | 26% | 40% | 36% | 18% | 27% | 26% | 26% | — |
| Net Profit | 22 | 24 | 17 | 30 | 68 | 47 | 29 | 134 | 362 | 61 | 92 | 132 | 139 |
| EPS in Rs | 2.81 | 2.95 | 1.9 | 3.22 | 7.08 | 4.65 | 2.7 | 12.53 | 33.77 | 5.67 | 8.6 | 12.32 | 12.93 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 3% | 18% | 12% | 8% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 79 | 83 | 87 | 92 | 97 | 102 | 107 | 107 | 107 | 107 | 107 | 107 |
| Reserves | 199 | 236 | 259 | 290 | 382 | 435 | 503 | 636 | 939 | 989 | 1,071 | 1,190 |
| Borrowings | 346 | 451 | 476 | 439 | 328 | 420 | 499 | 461 | 234 | 321 | 357 | 357 |
| Other Liabilities | 194 | 202 | 255 | 269 | 289 | 319 | 344 | 393 | 402 | 374 | 432 | 470 |
| Total Liabilities | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 | 1,792 | 1,968 | 2,124 |
| Fixed Assets | 444 | 660 | 698 | 669 | 636 | 808 | 774 | 902 | 1,042 | 1,048 | 1,269 | 1,231 |
| CWIP | 124 | 0 | 0 | 13 | 77 | 29 | 125 | 55 | 11 | 168 | 12 | 220 |
| Investments | 2 | 2 | 9 | 14 | 10 | 8 | 89 | 89 | 31 | 33 | 35 | 35 |
| Other Assets | 248 | 309 | 371 | 394 | 373 | 430 | 465 | 551 | 600 | 542 | 651 | 637 |
| Total Assets | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 | 1,792 | 1,968 | 2,124 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 65 | 50 | 142 | 153 | 202 | 122 | 132 | 168 | 429 | 164 | 197 | 338 |
| Investing | -52 | -132 | -109 | -75 | -55 | -188 | -163 | -147 | -169 | -223 | -170 | -312 |
| Financing | -2 | 91 | -33 | -76 | -145 | 65 | 58 | -38 | -255 | 49 | -5 | -46 |
| Net Cash Flow | 11 | 9 | 0 | 2 | 2 | 0 | 26 | -18 | 5 | -9 | 22 | -20 |
| Free Cash Flow | 13 | -82 | 52 | 72 | 113 | -35 | 6 | 42 | 260 | -79 | 53 | 9 |
| CFO/OP | 62 | 54 | 112 | 91 | 94 | 90 | 98 | 67 | 99 | 136 | 97 | 108 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 29 | 30 | 37 | 30 | 29 | 36 | 56 | 36 | 44 | 52 | 55 |
| Inventory Days | 50 | 82 | 79 | 89 | 125 | 167 | 126 | 101 | 90 | 101 | 108 | 97 |
| Days Payable | 65 | 77 | 98 | 80 | 67 | 73 | 81 | 66 | 42 | 38 | 75 | 101 |
| Cash Conversion Cycle | 10 | 34 | 11 | 45 | 89 | 123 | 81 | 90 | 84 | 107 | 86 | 50 |
| Working Capital Days | -83 | -80 | -97 | -72 | -11 | -22 | -34 | -1 | 17 | 1 | -5 | -4 |
| ROCE % | 13% | 11% | 12% | 13% | 22% | 12% | 9% | 21% | 38% | 5% | 10% | 13% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view TGV Sraac insights
29 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Board Meeting Intimation for Considering Audited Financial Results For The Fourth Quarter And Year Ended 31.03.2026 And Recommendatin Of Dividend, If Any.
13h - Board meets on 21 May 2026 to consider audited FY26 results and possible dividend. 13h - Board meets on 21 May 2026 to consider audited FY26 results and possible dividend.
2
Announcement Under Reg. 30 - Report On Relodgement Of Transfer Requests Of Physical Shares
13 Apr - March 2026 re-lodgement window update: no requests received, processed, approved or rejected. 13 Apr - March 2026 re-lodgement window update: no requests received, processed, approved or rejected.
3
Announcement Under Reg. 30 - Intimation Of Capacity Addition With Respect To Chloromethanes And Other Products.
10 Apr - Capacity increased effective April 10, 2026: KOH 27,150 TPA, chlorine 17,160, methylene chloride 17,817. 10 Apr - Capacity increased effective April 10, 2026: KOH 27,150 TPA, chlorine 17,160, methylene chloride 17,817.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
9 Apr - TGV SRAAC confirms it is not a large corporate; outstanding borrowing was Rs. 24.52 crore as of 31 March 2026. 9 Apr - TGV SRAAC confirms it is not a large corporate; outstanding borrowing was Rs. 24.52 crore as of 31 March 2026.
5
Announcement Under Reg.30 - Newspaper Publication
9 Apr - Submission of newspaper publication with regard to Special Window for lodgement/re-lodgement for transfer requests and "Saksham Niveshak" 100 days campaign for physical shareholders. 9 Apr - Submission of newspaper publication with regard to Special Window for lodgement/re-lodgement for transfer requests and "Saksham Niveshak" 100 days campaign for physical shareholders.
1
Announcement Reg. 30 - Special Window For Relodgement Of Transfer Requests Of Physical Shares. 7 Sept 2026
General_Announcements
2
Announcement Under Reg. 30 - Weblink Intimatiion To Shareholders - 44Th Annual Report 2025-26. 7 Sept 2026
General_Announcements
Frequently Asked Questions about TGV Sraac
What does TGV Sraac Ltd do?
Incorporated in 1981, TGV Sraac Ltd is a producer of Chlor-Alkali products, Chloromethane and also manufactures Castor Derivatives and Fatty Acids[1]
Where is TGV Sraac Ltd (507753) listed?
TGV Sraac Ltd trades as TGVSL on the NSE and under code 507753 on the BSE.
Which sector does TGV Sraac Ltd belong to?
TGV Sraac Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of TGV Sraac Ltd?
TGV Sraac Ltd has a market capitalisation of ₹1,133 Cr, which places it in the Small Cap band.
What is the PE ratio of TGV Sraac Ltd?
TGV Sraac Ltd trades at a PE ratio of 8.19, against a book value of ₹121.14 per share.
What is the 52-week high and low of TGV Sraac Ltd?
Over the last 52 weeks TGV Sraac Ltd has traded between ₹102.5 and ₹114.24.
Does TGV Sraac Ltd pay dividends?
TGV Sraac Ltd has a dividend yield of 0.93%.
What is the Return on Equity (ROE) of TGV Sraac Ltd?
TGV Sraac Ltd reported a return on equity of 10.18%. Its debt-to-equity ratio is 0.28.
Company Information
Incorporated in 1981, TGV Sraac Ltd is a producer of Chlor-Alkali products, Chloromethane and also manufactures Castor Derivatives and Fatty Acids[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/507753.md for TGV Sraac Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.